Us Bancorp \De\ Kiniksa Pharmaceuticals, Ltd. Transaction History

Us Bancorp \De\

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$17.63 - $21.74 $2,045 - $2,521	116 New	116 $2,000
Q1 2023 May 09, 2023	SELL	$10.7 - $15.79 $1,423 - $2,100	-133 Reduced 80.61%	32 $0
Q4 2022 Feb 13, 2023	SELL	$11.42 - $17.05 $9,524 - $14,219	-834 Reduced 83.48%	165 $2,000
Q3 2022 Oct 27, 2022	BUY	$9.76 - $13.41 $9,750 - $13,396	999 New	999 $13,000
Q2 2022 Aug 01, 2022	SELL	$7.6 - $11.41 $4,636 - $6,960	-610 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$9.3 - $12.37 $5,673 - $7,545	610 New	610 $6,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $680M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.